Evidence map›Paper›PMID 36769601›Full record

ArticleJournal of clinical medicine2023

Comparison of Clinical Outcomes, Risks, and Costs for 20,910 Donor In Vitro Fertilization and 16,850 Donor Artificial Insemination Treatment Cycles: A Retrospective Analysis in China.

Xue-Feng Luo, Hui-Lan Wu, Xi-Ren Ji, Yu-Lin Tang, Wen-Jun Zhou, Zeng-Hui Huang, Qian Liu, Li-Qing Fan, Chuan Huang, Wen-Bing Zhu

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Treatment experience of patients with failedFrontiers in public health · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xue-Feng LuoReproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China.ORCID 0000-0001-9632-7224
Hui-Lan WuReproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China.
Xi-Ren JiReproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China.
Yu-Lin TangInstitute of Reproductive and Stem Cell Engineering, Basic Medicine College, Central South University, Changsha 410000, China.
Wen-Jun ZhouInstitute of Reproductive and Stem Cell Engineering, Basic Medicine College, Central South University, Changsha 410000, China.
Zeng-Hui HuangInstitute of Reproductive and Stem Cell Engineering, Basic Medicine College, Central South University, Changsha 410000, China.
Qian LiuInstitute of Reproductive and Stem Cell Engineering, Basic Medicine College, Central South University, Changsha 410000, China.
Li-Qing FanReproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China.
Chuan HuangReproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China.
Wen-Bing ZhuReproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China.

Funding

National Natural Science Foundation of China 82001634
6 · The paper itself

Abstract

purposeTo evaluate the effectiveness of donor in vitro fertilization (IVF-D) and donor artificial insemination (AI-D) in clinical outcomes, risks, and costs.

methodsThis study analyzed the cycle changes and clinical outcomes in 20,910 IVF-D and 16,850 AI-D cycles between 2013 and 2021 in the Reproductive and Genetic Hospital of CITIC-Xiangya. A cost-effectiveness analysis was performed to evaluate the costs per couple and per live birth cycle in the two treatment groups.

resultsIVF-D had higher pregnancy and live birth rates than AI-D (

conclusionAI-D is more cost-effective and poses a lower risk for infertility couples than IVF-D, and patients should undergo three AI-D cycles to obtain the highest success rate.

Indexed as

artificial inseminationcost-effectivenesshuman sperm bankin vitro fertilizationsperm donor

Identifiers

PMID36769601
PMCPMC9917547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.